← Back to Search

Alpha-1 Blocker

Foley catheter for Urinary Retention (TEMPOUR Trial)

Phase 2
Waitlist Available
Led By Sebastien Drolet, MD FRCSC
Research Sponsored by CHU de Quebec-Universite Laval
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male patients of 18 years and older that are scheduled for a TEM resection during the study period.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights

TEMPOUR Trial Summary

This trial is evaluating whether the use of tamsulosin reduces the incidence of post-operative urinary retention in men who have undergone transanal endoscopic microsurgery.

TEMPOUR Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

TEMPOUR Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Post-Operative Urinary Retention (POUR) (yes or no)
Secondary outcome measures
Hospital admission
Indwelling catheter
Late POUR
+3 more

TEMPOUR Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: TamsulosinExperimental Treatment2 Interventions
The patients in the Experimental group will receive Tamsulosin Hydrochloride 0.4 MG (milligrams) once a day for 5 days before the surgery, one capsule on the day of the surgery and one on the day after. The intervention will consist of a total of 7 capsules
Group II: PlaceboPlacebo Group2 Interventions
The patients in the Placebo group will receive a placebo oral capsule (sugar) once a day for 5 days before the surgery, one capsule on the day of the surgery and one on the day after. The intervention will consist of a total of 7 capsules
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Foley catheter
2017
Completed Phase 2
~990
Tamsulosin
FDA approved

Find a Location

Who is running the clinical trial?

CHU de Quebec-Universite LavalLead Sponsor
167 Previous Clinical Trials
106,999 Total Patients Enrolled
1 Trials studying Urinary Retention
220 Patients Enrolled for Urinary Retention
Sebastien Drolet, MD FRCSCPrincipal InvestigatorCHU de Quebec-Universite Laval

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
UrologyJournal
Voiding Impairment After Prostate Biopsy: Does Tamsulosin Treatment Before Biopsy Decrease This Morbidity?
Bozlu, Murat, Ercüment Ulusoy, Erdal Doruk, Selahİttİn Çayan, Bülent Canpolat, Paul F. Schellhammer, and Erdem Akbay. 2003. “Voiding Impairment After Prostate Biopsy: Does Tamsulosin Treatment Before Biopsy Decrease This Morbidity?”. Urology. Elsevier BV. doi:10.1016/j.urology.2003.07.006.
International Journal of Radiation Oncology*Biology*PhysicsJournal
Prophylactic Tamsulosin (flomax) in Patients Undergoing Prostate 125I Brachytherapy for Prostate Carcinoma: Final Report of a Double-blind Placebo-controlled Randomized Study
Elshaikh, Mohamed A., James C. Ulchaker, Chandana A. Reddy, Kenneth W. Angermeier, Eric A. Klein, Nabil Chehade, Andrew Altman, and Jay P. Ciezki. 2005. “Prophylactic Tamsulosin (flomax) in Patients Undergoing Prostate 125I Brachytherapy for Prostate Carcinoma: Final Report of a Double-blind Placebo-controlled Randomized Study”. International Journal of Radiation Oncology*biology*physics. Elsevier BV. doi:10.1016/j.ijrobp.2004.09.036.
Annals of SurgeryJournal
Post–operative Urinary Retention
Jordan, Claus G.. 1933. “Post–operative Urinary Retention”. Annals of Surgery. Ovid Technologies (Wolters Kluwer Health). doi:10.1097/00000658-193307000-00012.
European UrologyJournal
The Effect of Tamsulosin on the Resting Tone and the Contractile Behaviour of the Female Urethra: A Functional Urodynamic Study in Healthy Women
REITZ, A. 2004. “The Effect of Tamsulosin on the Resting Tone and the Contractile Behaviour of the Female Urethra: A Functional Urodynamic Study in Healthy Women”. European Urology. Elsevier BV. doi:10.1016/j.eururo.2004.04.009.
All > Urinary Retention
~21 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top